Facile 3-chloro-1H-indazole based 1,3,4-thiadiazole derivatives as novel thymidine phosphorylase and anti-diabetic inhibitors: Experimental, in-vitro and molecular modelling approaches
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-025-04385-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Yousaf Khan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, COMSATS University Islamabad Campus, Islamabad, 45550, Pakistan. yousaf7n@gmail.com. Hauptthemen laut MEDLINE: Thiadiazoles, Thymidine Phosphorylase, Indazoles, Hypoglycemic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
A series of novel 3-chloro-1H-indazole-based 1,3,4-thiadiazole derivatives (1-15) were synthesized, characterized and evaluated for their inhibitory activity against thymidine phosphorylase and α-glucosidase. Several compounds showed potent dual inhibition, with compound 4 exhibiting the highest activity (IC50 = 4.70 ± 1.34 µM for thymidine phosphorylase and IC50 = 1.38 ± 0.46 µM for α-glucosidase), surpassing the standard inhibitors 7-deazaxanthine (IC50 = 12.42 ± 1.27 µM) and acarbose (IC50 = 5.97 ± 0.35 µM). Moreover, other synthesized derivatives included compounds 9, 2, 1 and 6 all showing improved inhibition profiles. Structure activity relationship analysis revealed that the nature and position of substituents on the phenyl ring play a critical role in modulating the enzyme inhibition potential. Similarly, molecular docking confirmed favorable binding interactions with the active sites of both enzymes, while ADMET profiling indicated good drug-likeness and pharmacokinetic potential. These findings suggest that thiadiazole-indazole hybrids represent promising lead candidates for the development of dual targets enzymes inhibitors with potential therapeutic applications in metabolic and proliferative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, COMSATS University Islamabad Campus, Islamabad, 45550, Pakistan. yousaf7n@gmail.com.
- Department of Chemistry, COMSATS University Islamabad Campus, Islamabad, 45550, Pakistan.
- Department of Chemistry, Hazara University, Mansehra, 21120, Pakistan.
- Department of Chemistry, Abbottabad University of Science and Technology (AUST, Abbottabad, 22500, Pakistan.
- Department of Information System, Faculty of Computing and Information Technology, Northern Border University, Rafha, Saudi Arabia.
- Department of Computer Science, COMSATS University Islamabad Campus, Islamabad, 45550, Pakistan.
Zitieren
APA
Khan, Y., Maalik, A., Rehman, W., Sarfraz, H., Hussain, R., Khan, S., Kouki, M., Usman, A., & Adnan, R. (2026). Facile 3-chloro-1H-indazole based 1,3,4-thiadiazole derivatives as novel thymidine phosphorylase and anti-diabetic inhibitors: Experimental, in-vitro and molecular modelling approaches. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04385-4
Vancouver
Khan Y, Maalik A, Rehman W, Sarfraz H, Hussain R, Khan S, et al. Facile 3-chloro-1H-indazole based 1,3,4-thiadiazole derivatives as novel thymidine phosphorylase and anti-diabetic inhibitors: Experimental, in-vitro and molecular modelling approaches. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04385-4
BibTeX
@article{Khan2026,
author = {Khan, Yousaf and Maalik, Aneela and Rehman, Wajid and Sarfraz, Hina and Hussain, Rafaqat and Khan, Shoaib and Kouki, Marouan and Usman, Aisha and Adnan, Rubina},
title = {Facile 3-chloro-1H-indazole based 1,3,4-thiadiazole derivatives as novel thymidine phosphorylase and anti-diabetic inhibitors: Experimental, in-vitro and molecular modelling approaches},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-025-04385-4}
}
EUVIMED